Tranxene and Epivir drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tranxene (clorazepate dipotassium) and Epivir (lamivudine). Common drug interactions include weight decreased among females and giardiasis among males.

The phase IV clinical study analyzes what interactions people have when they take Tranxene and Epivir. It is created by eHealthMe based on reports of 25 people who take the same drugs from the FDA, and is updated regularly.

What is Tranxene?

Tranxene has active ingredients of clorazepate dipotassium. It is often used in stress and anxiety. eHealthMe is studying from 6,550 Tranxene users. Check the latest studies of Tranxene.

What is Epivir?

Epivir has active ingredients of lamivudine. It is often used in hiv infection. eHealthMe is studying from 16,870 Epivir users. Check the latest studies of Epivir.

On Jul, 13, 2026

25 people who take Tranxene and Epivir together, and have interactions are studied.

What are the common drug interactions of Tranxene and Epivir, by gender? *:

female:

Weight decreased
Anaemia (lack of blood)
Neutropenia (an abnormally low number of neutrophils)
Renal failure acute (rapid kidney dysfunction)
Thrombocytopenia (decrease of platelets in blood)
Abdominal pain
Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
General physical health deterioration (weak health status)
Hypertriglyceridaemia (excess of triglycerides in the blood)
Hypocholesterolaemia (presence of abnormally small amounts of cholesterol in the circulating blood)

male:

Giardiasis (intestinal infection caused by the parasite giardia lamblia)
Alanine aminotransferase increased
Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
Abnormal behaviour
Anuria (failure of the kidneys to produce urine)
Asthenia (weakness)
Blood alkaline phosphatase increased
Blood bilirubin increased
Blood pressure decreased
C-reactive protein increased

What are the common drug interactions of Tranxene and Epivir, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Tachypnoea (a condition of rapid breathing over 20 per minute)
Thrombocytopenia (decrease of platelets in blood)
Vomiting
Abdominal pain upper
Abdominal rigidity
Abnormal behaviour
Acidosis (build-up of carbon dioxide in the blood)
Ascites (accumulation of fluid in the abdominal cavity)
Asthenia (weakness)
Blood creatine increased

40-49:

Neutropenia (an abnormally low number of neutrophils)
Palpitations (feelings or sensations that your heart is pounding or racing)
Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
Anaemia (lack of blood)
Blood alkaline phosphatase increased
Blood pressure decreased
Chest pain
Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
Electrocardiogram t wave amplitude decreased
Heart rate increased

50-59:

Anaemia (lack of blood)
Blood albumin decreased
Drug level above therapeutic
Hepatitis cholestatic (flow of bile from the liver is slowed or blocked)

60+:

n/a

What are the existing conditions these people have? *

Hepatitis B: 2 people, 8.00%

* Approximation only. Some reports may have incomplete information.

Do you take Tranxene and Epivir?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously